Annexin A1 expression and its prognostic significance in human breast cancer

Neoplasma

Volumn 57, Issue 3, 2010, Pages 253-259

  Wang, L P ^a   Bi, J ^a   Yao, C ^a   Xu, X D ^a   Li, X X ^a   Wang, S M ^a   Li, Z L ^a   Zhang, D Y ^a   Wang, M ^a   Chang, G Q ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Annexin A1; Breast cancer; Metastasis; Tissue microarray

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; LIPOCORTIN 1; METHOTREXATE; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST LESION; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE MARKER; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; MYOEPITHELIUM CELL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; BREAST TUMOR; CHEMISTRY; FEMALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A1; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS;

EID: 77954628285     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_03_253     Document Type: Article

References (26)

1. JEMAL A, SIEGEL R, WARD E, MURRAY T, XU J et al.:. Cancer statistics.2007. CA Cancer J Clin 2007; 57, 43-66. doi:10.3322/canjclin.57.1.43
2. KIM KM, KIM DK, PARK YM, KIM CK, Na DS Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 1994; 343: 251-255. doi:10.1016/0014-5793(94)80566-0
3. ALLDRIDGE LC, BRYANT CE Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003; 290: 93-107. doi:10.1016/S0014-4827(03)00310-0
4. BAI XF, NI XG, ZHAO P, LIU SM, WANG HX et al.: Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10, 1466-1470.
5. MASAKI T, TOKUDA M, OHNISHI M, WATANABE S, FUJIMURA T et al.: Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24, 72-81.
6. WU W, TANG X, HU W, LOTAN R, HONG WK et al.: Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002; 19, 319-326. doi:10.1023/A:1015515119300
7. LUO A, KONG J, HU G, LIEW CC, XIONG M et al.: Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004; 23, 1291-1299. doi:10.1038/sj.onc.1207218
8. KANG JS, CALVO BF, MAYGARDEN SJ, CASKEY LS, MOHLER JL et al.: Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002; 8, 117-123.
9. HIPPO Y, YASHIRO M, ISHII M, TANIGUCHI H, TSUTSUMI S et al.: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61, 889-895.
10. LIANG L, QU L, DING Y Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials. Cancer Invest 2007; 25: 427-434. doi:10.1080/07357900701512258
11. SILISTINO-SOUZA R, RODRIGUES-LISONI FC, CURY PM, Maniglia JV, Raposo LS et al.: Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 2007; 120, 2582-2589. doi:10.1002/ijc.22639
12. BRICHORY FM, MISEK DE, YIM AM, KRAUSE MC, GIORDANO TJ et al.: An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 2001; 98: 9824-9829. doi:10.1073/pnas.171320598 13] YU GZ, WANG JJ, CHEN YJ, WANG X, PAN J et al.: Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 2008; 25, 695-702. doi:10.1007/s10585-008-9178-y
13. KONONEN J, BUBENDORF L, KALLIONIEMI A, BARLUND M, SCHRAML P et al.: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4, 844-847. doi:10.1038/nm0798-844
14. CAO Y, LI Y, EDELWEISS M, ARUN B, ROSEN D et al.: Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 2008; 16, 530-4. doi:10.1097/PAI.0b013e31817432c3
15. AHN SH, SAWADA H, RO JY, NICOLSON GL Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997; 15: 151-156. doi:10.1023/ A:1018452810915
16. LIM LHK, PERVAIZ S Annexin 1: the new face of an old molecule. Faseb Journal 2007; 21: 968-975. doi:10.1096/fj.06-7464rev
17. SHEN DJ, NOORAIE F, ELSHIMALI Y, LONSBERRY V, HE JB et al.: Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Human Pathology 2006; 37: 1583-1591. doi:10.1016/j.humpath.2006.06.001
18. KREUNIN P, URQUIDI V, LUBMAN DM, GOODISON S Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique. Proteomics 2004; 4: 2754-2765. doi:10.1002/ pmic.200300767
19. KREUNIN P, YOO C, URQUIDI V, LUBMAN DM, GOODISON S Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 2007; 7: 299-312. doi:10.1002/pmic.200600272
20. HSIEH SY, HSU CY, HE JR, LIU CL, LO SJ et al.: Identifying Apoptosis-Evasion Proteins/Pathways in Human Hepatoma Cells via Induction of Cellular Hormesis by UV Irradiation. Journal of Proteome Research 2009; 8, 3977-3986. doi:10.1021/pr900289g
21. ALLDRIDGE LC, BRYANT CE Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Experimental Cell Research 2003; 290: 93-107. doi:10.1016/S0014-4827(03)00310-0
22. PENCIL SD, TOTH M Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis 1998; 16: 113-121. doi:10.1023/A:1021917017109
23. YI M, SCHNITZER JE Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 17886-17891. doi:10.1073/ pnas.0901324106
24. LUTHRA R, SINGH RR, LUTHRA MG, LI YX, HANNAH C et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27, 6667-6678. doi:10.1038/onc.2008.256
25. HAO XS, SUN BC, HU LM, LAHDESMAKI H, DUNMIRE V et al.: Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 2004; 100, 1110-1122. doi:10.1002/cncr.20095
26. FENG YM, SUN BC, LI XQ, ZHANG L, NIU Y et al.: Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Research and Treatment 2007; 103, 319-329. doi:10.1007/s10549-006-9385-7